Message Font: Serif | Sans-Serif
No. of Recommendations: 2
Well, the possibility of Novartis taking over Roche continues to gain attention:

Two things intrigued me. First, Novartis is said to have deep pockets, which would be a good thing for Genentech if some of that money goes to support its pipeline, which I think is the best in the business. Second, this article speculates on the strengths of the "new" biotech firm that would come from the merger of Roche's Genentech and Novartis' Chiron.

Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.